The pandemic isn't over, but there has been tremendous progress in the fight against it. And now, investors are abandoning many of those companies that made contributions to helping curb the spread of the disease.

While it is true that some of those corporations might now have concerning prospects, others still look like excellent long-term investments. Two examples are Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA). Let's see why.

Pfizer has been one of the most successful companies in the coronavirus vaccine market with Comirnaty. It also owns a successful therapy for the disease, Paxlovid. These two products have helped revenue soar in the past couple of years. But investors believe that demand for coronavirus vaccines and medicines will drop substantially starting next year.

Continue reading

Source Fool.com